Glessner Coleen — SEC Form 4 filings
SEC reporting owner CIK 1919170. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-04 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 30,608 shares, $306,080 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 30,608 shares @ $10.00 ($306,080) in Emergent BioSolutions Inc., filed 2025-10-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | EVP, Quality & Ethics, and CPL | 15 | — | 1 leg · 30,608 sh · $306,080 | 19 |
Form 4 filings — Glessner Coleen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 2,018 @ $8 | EDGAR |
| 2026-05-01 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 100,111 @ $0 | EDGAR |
| 2026-03-05 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 8,199 @ $8.44 · Grant/award (A): 44,834 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 313 @ $8.15 | EDGAR |
| 2026-02-10 | 4 | Emergent BioSolutions Inc. (EBS) | Disposition to issuer (D): 28,847 @ $10.92 · Tax withholding (F): 2,852 @ $10.92 | EDGAR |
| 2025-10-16 | 4 | Emergent BioSolutions Inc. (EBS) | Sale (S): 30,608 @ $10 | EDGAR |
| 2025-06-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 1,249 @ $6.63 | EDGAR |
| 2025-04-09 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 480 @ $4.44 | EDGAR |
| 2025-03-10 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 62,500 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Emergent BioSolutions Inc. (EBS) | Disposition to issuer (D): 5,913 @ $0 · Disposition to issuer (D): 24,078 @ $0 · Tax withholding (F): 313 @ $7.48 | EDGAR |
| 2024-12-10 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 18,674 @ $9.01 | EDGAR |
| 2024-06-11 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 1,249 @ $6.19 | EDGAR |
| 2024-04-09 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 585 @ $2.29 | EDGAR |
| 2024-03-15 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Emergent BioSolutions Inc. (EBS) | Tax withholding (F): 381 @ $3.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1919170 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →